Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Denmark

European Innovation Council · Running

KvasirAccelerator The first utility-oriented, agnostic software platform for quantum-centric drug discovery

Coordinator
Kvantify Aps, Denmark
Runs
1 August 2023 to 31 July 2025
Status
Running
EU funding
€2.5m
Total cost
€4.5m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190124924

What the project is doing

In the project's own words, from its summary on CORDIS.

Humanity is exploring the limits of computing to solve the world’s biggest challenges with unprecedented speed and precision. While quantum hardware is being matured into a commercial technology, there is still no quantum software capable of addressing real business problems. Furthermore, quantum computing will inevitably exacerbate the complexity of current computational workflows for non-coding experts to extract knowledge.

At Kvantify, we are developing Kvaser, the first platform-agnostic, explainable, customer-centric quantum software tool, to be operated by the end-user. With EIC funding, we will develop advanced algorithms for quantum chemistry and machine learning that will solve real-life drug R&D problems beyond the scope of classical resources. Kvaser will empower R&D scientists to run molecular and biochemical simulations on modern hardware with unmatched speed and accuracy, enabling high precision quantum chemistry calculations for efficient and accelerated drug discovery.

Topics

Who is involved

OrganisationCityCountryRole
Kvantify ApsKobenhavn ODenmarkCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI